GLP-1-Based Therapeutics Summit - Industry News

Advancing Specialized, Durable, & Efficacious GLP-1s & Investigating Commercial Opportunity to Crystallize Pipeline Strategy & Indication Expansion

May 15-16, 2024 | Philadelphia, PA

Save $400 - Offer Ends this Friday, April 12!


Welcome to the Inaugural GLP-1-Based Therapeutics Summit!

Elucidate Strategies for Product Specialization & Indication Expansion through Pharmacoeconomic Analysis

Amidst the resounding success of Novo’s SELECT trial, the clinical trial landscape finds itself inundated with a surge of innovative GLP-1 treatments. Each passing week witnesses the unveiling of new multi-million-dollar investments, propelling GLP-1 players to the forefront of pharmaceutical revenue growth.  

Uniting the industry decision-makers behind the explosion of GLP-1 assets, the GLP-1-Based Therapeutics Summit stands as a pivotal platform. Uniquely positioned, it serves as the nexus for industry decision-makers, providing invaluable insights to guide therapeutic strategies, enabling the development of the right drugs for patients at the right price.

Built with insights from industry giants including Eli Lilly, Novo Nordisk, Amgen, Carmot Therapeutics, Altimmune, and Pfizer, join 60+ industry leaders in Product Planning, Clinical Development, Medical Research, and Commercial Strategy.

"What a great forum for bringing together brilliant minds and creating an environment for fostering collaboration and accelerating progress in a very exciting area"
Seulki Lee, Chief Executive Officer, D&D Pharmatech

Together, We Will:

GLP-1-Based Therapeutics Summit

Explore the latest paradigm shifts in clinical trials to develop more durable, efficacious, and orally available therapies

GLP-1-Based Therapeutics Summit

Evaluate the evolving industry landscape to collaboratively map out the next steps for GLP-1 development

GLP-1-Based Therapeutics Summit

Assess the pipelines of key players to design GLP-1 therapies that stand out in a growing and highly competitive market

Download the Full Agenda for More Information on:

    • 15+ GLP-1 Industry Expert Speakers
    • 8+ Hours of Industry Networking
    • & Much More!


Full Agenda - GLP-1-Based Therapeutics Summit

World-Class Speaker Faculty Includes:

We are in a unique time where the industry is leveraging over 50 years of incretin biology to create impactful therapies for patients with metabolic disease. This summit provides an exciting forum to discuss what comes next as we seek to serve more patients with unmet needs
Seulki Lee, Chief Executive Officer, D&D Pharmatech

Our Partners